Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Size/SKU | Availability | Price |
|---|---|---|
1 mg | Check Cart for Availability | $546.00 |
About This Item
Form:
essentially salt-free, lyophilized powder
Assay:
98-100%
Biological source:
human
Other Notes
Occurs as 3 major phenotypes: type 1-1, type 2-1, type 2-2.
Disclaimer
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
1 of 1
This Item | |||
|---|---|---|---|
| description 98-100%, essentially salt-free, lyophilized powder | description IgG fraction of antiserum, lyophilized powder | description clone HG-36, ascites fluid | description - |
| assay 98-100% | assay - | assay - | assay - |
| technique(s) cell culture | mammalian: suitable | technique(s) indirect ELISA: 1:30,000 | technique(s) indirect ELISA: 1:4,000 | technique(s) western blot: 1:500-1:2000, immunohistochemistry: 1:50-1:200 |
| biological source human | biological source rabbit | biological source mouse | biological source rabbit |
| form essentially salt-free, lyophilized powder | form lyophilized powder | form - | form liquid |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. −20°C | storage temp. −20°C |
| Gene Information human ... HP(3240) | Gene Information human ... HP(3240) | Gene Information human ... HP(3240) | Gene Information human ... HP(3240) |
Storage Class
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.



